domingo, 26 de febrero de 2023

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study - The Lancet Rheumatology

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario